Lilly names new head of cancer drug business

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Eli Lilly and Co. on Friday named company insider Sue Mahony as president of its cancer drug business.

Mahony is replacing John Johnson, who resigned Jan. 28 to become CEO of East Brunswick, N.J.-based biotechnology company Savient Pharmaceuticals Inc. Johnson is the former CEO of ImClone Systems, which Lilly acquired in 2008.

The change is effective immediately. Mahony has worked at Eli Lilly for about 10 years, the company said. Before her promotion she was in charge of human resources and diversity.

The company said her earlier positions included general manager of its Canadian business. She worked for other drugmakers, including Amgen Inc., Bristol-Myers Squibb Co., and Schering-Plough Corp. for about 10 years before joining Eli Lilly.

Mahony was featured as a "Woman of Influence" by IBJ in 2010.

The company said Steve Fry will assume Mahony's previous human resources and diversity position. Fry was in charge of human resources for Lilly's bio-medicines and emerging markets units.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news. ONLY $1/week Subscribe Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In